Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Inhibikase Therapeutics, Inc. (IKT)  
$0.61 0.00 (0.00%) as of 4:30 Thu 6/29


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 10,100,000
Market Cap: 6.16(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.528 - $0.7633
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Inhibikase Therapeutics is a clinical stage pharmaceutical company developing therapeutics for Parkinson's Disease and related disorders that arise inside and outside of the brain. Co. has commenced clinical development of IkT-148009, a small molecule Abelson Tyrosine Kinase inhibitor. Co. has also advanced clinical batch manufacturing and pill formulation for its platform prodrug technology involving IkT-001Pro. Co.'s platform drug discovery and delivery technologies have identified additional opportunities, including a treatment for bacterial or viral infections in the brain using a single agent at fixed dose, and an oncology opportunity in stable-phase Chronic Myelogenous Leukemia.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 23,948
Total Buy Value $0 $0 $0 $17,423
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 4
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 11
  Page 1 of 1  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Werner Milton H. President and CEO   •       •       •   2022-08-16 4 B $0.80 $4,000 D/D 5,000 5,335,433 3.15 -39%     
   Werner Milton H. President and CEO   •       •       •   2022-05-27 4 B $0.98 $4,880 D/D 5,000 5,330,433 3.15 -6%     
   Werner Milton H. President and CEO   •       •       •   2022-05-20 4 B $0.60 $6,000 D/D 10,000 5,325,433 3.15 39%     
   Frattaroli Joseph Chief Financial Officer   •       –      –    2022-05-19 4 B $0.64 $2,543 D/D 3,948 48,091 2.66 37%     
   Werner Milton H. President and CEO   •       •       •   2022-01-03 4 OE $2.02 $44,143 D/D 21,853 5,315,433     -
   Werner Milton H. President and CEO   •       •       •   2021-11-17 4 B $1.93 $46,558 I/I 23,589 23,589 2.64 -25%     
   Werner Milton H. President and CEO   •       •       •   2021-08-17 4 OE $2.02 $44,143 D/D 21,853 5,293,580     -
   Werner Milton H. President and CEO   •       •       •   2021-05-14 4 D $4.59 $77,654 D/D (16,918) 5,271,727     -
   Werner Milton H. President and CEO   •       •       •   2021-05-14 4 OE $0.38 $16,609 D/D 43,707 5,288,645     -
   Frattaroli Joseph Chief Financial Officer   •       –      –    2020-12-28 4 OE $10.00 $441,430 I/I 44,143 44,143     -
   Werner Milton H. President and CEOOfficer   •       •       •   2020-12-22 3 IO $0.00 $0 D/D 0 5,244,938     -

  11 Records found
  1    
  Page 1 of 1
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed